A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease-Reference-Cited by-同舟云学术

A new brain‐penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease

Author:

Fujii Takahiro¹,Tanaka Yuta¹^ORCID,Oki Hideyuki²,Sato Sho³,Shibata Sachio²,Maru Takamitsu²,Tanaka Yuta⁴,Tanaka Maiko¹,Onishi Tomohiro¹^ORCID

Affiliation:

1. Neuroscience Drug Discovery Unit, Research, Takeda Pharmaceutical Company Limited Fujisawa Kanagawa Japan

2. Discovery Biology, Discovery Science Axcelead Drug Discovery Partners, Inc. Fujisawa Kanagawa Japan

3. Drug Metabolism and Pharmacokinetics Research Laboratories Research, Takeda Pharmaceutical Company Limited Fujisawa Kanagawa Japan

4. Drug Discovery Sciences Research, Takeda Pharmaceutical Company Limited Fujisawa Kanagawa Japan

Funder

Takeda Pharmaceutical Company

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

Reference41 articles.

2. Gaucher disease: New expanded classification emphasizing neurological features;Alaei M. R.;Iranian Journal of Child Neurology,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献